Suppr超能文献

经皮射频与微波消融治疗肝细胞癌的疗效及生存分析:埃及多学科诊所经验

Efficacy and survival analysis of percutaneous radiofrequency versus microwave ablation for hepatocellular carcinoma: an Egyptian multidisciplinary clinic experience.

作者信息

Abdelaziz Ashraf, Elbaz Tamer, Shousha Hend Ibrahim, Mahmoud Sherif, Ibrahim Mostafa, Abdelmaksoud Ahmed, Nabeel Mohamed

机构信息

Endemic Hepatogastroenterology Department, Faculty of Medicine, Kasr Al Ainy Hospital, Cairo University, Cairo, 11562, Egypt.

出版信息

Surg Endosc. 2014 Dec;28(12):3429-34. doi: 10.1007/s00464-014-3617-4. Epub 2014 Jun 17.

Abstract

BACKGROUND

Hepatocellular carcinoma (HCC) is a primary tumor of the liver with poor prognosis. For early stage HCC, treatment options include surgical resection, liver transplantation, and percutaneous ablation. Percutaneous ablative techniques (radiofrequency and microwave techniques) emerged as best therapeutic options for nonsurgical patients.

AIMS

We aimed to determine the safety and efficacy of radiofrequency and microwave procedures for ablation of early stage HCC lesions and prospectively follow up our patients for survival analysis.

PATIENTS AND METHODS

One Hundred and 11 patients with early HCC are managed in our multidisciplinary clinic using either radiofrequency or microwave ablation. Patients are assessed for efficacy and safety. Complete ablation rate, local recurrence, and overall survival analysis are compared between both procedures.

RESULTS

Radiofrequency ablation group (n = 45) and microwave ablation group (n = 66) were nearly comparable as regards the tumor and patients characteristics. Complete ablation was achieved in 94.2 and 96.1% of patients managed by radiofrequency and microwave ablation techniques, respectively (p value 0.6) with a low rate of minor complications (11.1 and 3.2, respectively) including subcapsular hematoma, thigh burn, abdominal wall skin burn, and pleural effusion. Ablation rates did not differ between ablated lesions ≤ 3 and 3-5 cm. A lower incidence of local recurrence was observed in microwave group (3.9 vs. 13.5% in radiofrequency group, p value 0.04). No difference between both groups as regards de novo lesions, portal vein thrombosis, and abdominal lymphadenopathy. The overall actuarial probability of survival was 91.6% at 1 year and 86.1% at 2 years with a higher survival rates noticed in microwave group but still without significant difference (p value 0.49).

CONCLUSION

Radiofrequency and microwave ablations led to safe and equivalent ablation and survival rates (with superiority for microwave ablation as regards the incidence of local recurrence).

摘要

背景

肝细胞癌(HCC)是一种预后较差的原发性肝癌。对于早期HCC,治疗选择包括手术切除、肝移植和经皮消融。经皮消融技术(射频和微波技术)已成为非手术患者的最佳治疗选择。

目的

我们旨在确定射频和微波消融早期HCC病变的安全性和有效性,并对患者进行前瞻性随访以进行生存分析。

患者与方法

111例早期HCC患者在我们的多学科诊所接受射频或微波消融治疗。对患者进行疗效和安全性评估。比较两种治疗方法的完全消融率、局部复发率和总生存分析。

结果

射频消融组(n = 45)和微波消融组(n = 66)在肿瘤和患者特征方面几乎具有可比性。分别采用射频和微波消融技术治疗的患者中,完全消融率分别为94.2%和96.1%(p值0.6),轻微并发症发生率较低(分别为11.1%和3.2%),包括包膜下血肿、大腿烧伤、腹壁皮肤烧伤和胸腔积液。≤3 cm和3 - 5 cm的消融病变之间的消融率无差异。微波组局部复发率较低(3.9%,而射频组为13.5%,p值0.04)。两组在新发病变、门静脉血栓形成和腹部淋巴结病方面无差异。1年时总生存精算概率为91.6%,2年时为86.1%,微波组生存率较高,但仍无显著差异(p值0.49)。

结论

射频和微波消融导致安全且相当的消融率和生存率(就局部复发发生率而言,微波消融更具优势)。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验